A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults

NCT04238975 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

213

Enrollment

INDUSTRY

Sponsor class

Conditions

Tetanus
Diphtheria
Whooping Cough

Interventions

BIOLOGICAL: GC3111 vaccine
BIOLOGICAL: Boostrix® vaccine

Sponsor

Green Cross Corporation